Polybenzamide mustards: Structure-activity relationships for DNA sequence-specific alkylation

Anti-Cancer Drug Design

Volumn 14, Issue 1, 1999, Pages 61-70

  Turner, Paul R ^a   Ferguson, Lynnette R ^a   Denny, William A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Footprinting; Minor groove alkylator; Mustard; Polybenzamide

Indexed keywords

BENZAMIDE DERIVATIVE; DNA;

ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA ALKYLATION; DNA SEQUENCE; HYDROGEN BOND; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADENINE; ALKYLATION; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BENZAMIDES; CATTLE; DNA; DNA FOOTPRINTING; DNA, BACTERIAL; ESCHERICHIA COLI; GUANINE; IN SITU NICK-END LABELING; NITROGEN MUSTARD COMPOUNDS; PLASMIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

BRASSICACEAE;

EID: 0032910807     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Atwell G.J., Yaghi B.M., Turner P.R., Boyd M., O'Connor C.J., Ferguson L.R., Baguley B.C., Denny W.A. (1995) Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards. Bioorganic and Medicinal Chemistry, 6, 679.
2. Bank B.B. (1992) Studies of chlorambucil-DNA adducts. Biochemical Pharmacology, 44, 571.
3. Beran M., Jeha S., OBrien S., Estey E., Vitek L., Zurlo M.G., Rios M.B., Keating M., Kantarjian H. (1997) Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a Phase I study. Clinical Cancer Research, 3, 2377.
4. Broggini M., Coley H.M., Mongelli N., Pesenti E., Wyatt M.D., Hartley J.A., d'Incalci M. (1995) DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acids Research, 23, 81.
5. Denny W.A. (1998) New developments in the use of nitrogen mustard alkylating agents as anticancer drugs. In Advances in DNA Sequence-specific Agents, Volume 3. Palumbo, M. (ed.), p. 157. JAI Press: Greenwich, CT.
6. Denny W.A., Atwell G.J., Baguley B.C., Cain B.F. (1979) Potential antitumor agents. Part 29. QSAR for the antileukemic bisquaternary ammonium heterocycles. Journal of Medicinal Chemistry, 22, 134.
7. Gravatt G.L., Baguley B.C., Wilson W.R., Denny W.A. (1994) DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove targeted aniline mustard analogues of pibenzimol (Hoechst 33258). Journal of Medicinal Chemistry, 37, 4338.
8. Hartley J.A., Wyatt M.D., Garbiras B.J., Richter C., Lee M. (1994) Probing the importance of the second chloroethyl arm of a benzoic acid mustard derivative of an imidazolecontaining analogue of distamycin. Bioorganic and Medicinal Chemistry Letters, 4, 2412.
9. Kohn K.W., Hartley J.A., Mattes W.B. (1987) Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards. Nucleic Acids Research, 15, 10531.
10. Lee M., Rhodes A.L., Wyatt M.D., d'Incalci M., Forrow S., Hartley J.A. (1993) In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin. Journal of Medicinal Chemistry, 36, 863.
11. Lee M., Simpson J.E., Woo S., Kaenzig C., Anlezark G.M., Enoamooquaye E., Burke P.J. (1997) Synthesis of an aminopropyl, analog of the experimental anticancer drug tallimustine, and activation of its 4-nitrobenzylcarbamoyl prodrug by nitroreductase and NADH. Bioorganic and Medicinal Chemistry Letters, 7, 1065.
12. Mattes W.B., Hartley J.A., Kohn K.W. (1986a) Mechanism of DNA strand breakage by piperidine at sites of N7-alkylguanines. Biochimica et Biophysica Acta, 868, 71.
13. Mattes W.B., Hartley J.A., Kohn K.W. (1986b) DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Research, 14, 2971.
14. Maxam A.M., Gilbert W. (1980) Sequencing end-labeled DNA with base-specific chemical cleavages. Methods in Enzymology, 65, 499.
15. Millard J.T., Raucher S., Hopkins P.B. (1990) Mechlor-ethamine crosslinks deoxyguanosine residues at 5′-GNC sequences in duplex DNA fragments. Journal of the American Chemical Society, 112, 2459.
16. Pieper R.O., Erickson L.C. (1990) DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. Carcinogenesis, 11, 1739.
17. Prakash A.S., Denny W.A., Gourdie T.A., Valu K.K., Woodgate P.D., Wakelin L.P.G. (1990) DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards. Biochemistry, 29, 9799.
18. Prakash A.S., Valu K.K., Wakelin L.P.G., Woodgate P.D., Denny W.A. (1991) Synthesis and antitumour activity of the spatially-separated mustard bis-N,N′-[3-(N-(2-chloroethyl)-N-ethyl)amino-5-((N,N-dimethylamino)- methyl)aminophenyl]-1,4-benzenedicarboxamide, which alkylates DNA exclusively at adenines in the minor groove. Anti-Cancer Drug Design, 6, 195.
19. Richardson K.K., Fostel J., Skopek T.R. (1983) Nucleotide sequence of the xanthine guanine phosphoribosyl transferase gene of E. coli. Nucleic Acids Research, 11, 8809.
20. Sambrook J., Fritsch E.F., Maniatis T. (1989) Molecular Cloning, A Laboratory Manual. Cold Spring Harbour, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
21. Smaill J.B., Fan, J.-Y., Papa P.V., O'Connor C.J., Denny W.A. (1998) Mono-and difunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA. Anti-Cancer Drug Design, in press.
22. Turner P.R., Ferguson L.R., Denny W.A. (1998) Binding of polybenzamides to DNA: studies by DNase I and chlorambucil interference footprinting and comparison with Hoechst 33258. Anti-Cancer Drug Design, in press.
23. Wong S.S., Sturm R.A., Michel J., Zhang X.M., Danoy P.A., McGregor K., Jacobs J.J., Kaushal A., Dong Y., Dunn I.S., Parsons P.G. (1994) Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells. Biochemical Pharmacology, 47, 827.
24. Wyatt M.D., Lee M., Garbiras B.J., Souhami R.L., Hartley J.A. (1995) Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity. Biochemistry, 34, 13034.